Skip to main content

Sign up for our newsletter.

Quality journalism. Progressive values. Direct to your inbox.

Sen. Bernie Sanders (I-Vt.) speaks at the Hotel Vermont on March 11, 2020 in Burlington. (Photo: Scott Eisen/Getty Images)

Sen. Bernie Sanders (I-Vt.) speaks at the Hotel Vermont on March 11, 2020 in Burlington. (Photo: Scott Eisen/Getty Images)

'Congress Must End This National Embarrassment,' Says Sanders After CBO Reveals High Drug Prices for Medicare Part D

"There is no rational reason why Medicare pays nearly three times more than Medicaid and about twice as much as the VA for the same exact medicine."

Jessica Corbett

Sen. Bernie Sanders on Thursday responded with outrage and a demand for reform after a new federal analysis revealed that Medicare Part D, which is utilized by tens of millions of Americans, pays far more for prescription medications than any other government health program.

"It is time for Congress to take on the greed of the pharmaceutical industry and require Medicare to negotiate lower drug prices."
—Sen. Bernie Sanders

Sanders (I-Vt.) commissioned the new Congressional Budget Office (CBO) report on Medicare Part D, an optional prescription drug benefit for people with Medicare that is provided through private insurers. The majority of those with Medicare are enrolled in a Part D plan.

The CBO analysis focused on the prices of 176 top-selling brand-name drugs and found an average net price of $343 for Medicare Part D. That compared with $118 for Medicaid, $190 for the Department of Veterans Affairs, $184 for the Department of Defense, and $272 for the DoD TRICARE retail pharmacy network.

The report noted that "the much lower net prices in Medicaid are the result of higher manufacturer rebates in that program than in Medicare Part D." For specialty drugs, the average price ranges from $1,889 in Medicaid to $4,293 in Medicare Part D.

"There is no rational reason why Medicare pays nearly three times more than Medicaid and about twice as much as the VA for the same exact medicine," Sanders declared.

"Negotiating directly with pharmaceutical companies will substantially reduce the price of prescription drugs, and it is a national embarrassment that the secretary of Health and Human Services is prohibited from doing that on behalf of the more than 40 million Americans who get their prescription drug coverage from Medicare Part D," he added. "It is time for Congress to take on the greed of the pharmaceutical industry and require Medicare to negotiate lower drug prices."

The CBO report follows the January release of a Government Accountability Office (GAO) study, also commissioned by Sanders, which found that in a "sample of 399 brand-name and generic prescription drugs, the VA paid an average of 54% less per unit than Medicare, even after taking into account rebates and discounts."

The GAO study, which involved 2017 data, revealed that the VA paid at least 50% less for 233 of the medicines and at least 75% less for 106 of them.

Sanders has repeatedly taken on the pharmaceutical industry with legislative proposals. In 2018, he and Rep. Ro Khanna (D-Calif.) unveiled the Prescription Drug Price Relief Act, which Social Security Works called "Big Pharma's worst nightmare."

Highlighting that legislation in response to the CBO report, Sanders' office said Thursday that the bill "would cut prescription drug prices in half by pegging prices in the United States to median drug prices in five major countries: Canada, the United Kingdom, France, Germany, and Japan."

Medicare coverage is generally restricted to people age 65 or older, younger people with disabilities, and those with permanent kidney failure requiring dialysis or transplant—but Sanders has long advocated for Medicare for All.

Last week, a panel of policy experts and medical professionals who examined the healthcare legacy of the Trump administration released a report stating that its policies did not "represent a radical break with the past but have merely accelerated the decadeslong trend of lagging life expectancy that reflects deep and long-standing flaws in U.S. economic, health, and social policy."

They concluded that "single-payer, Medicare for All reform is the only way forward."


Our work is licensed under Creative Commons (CC BY-NC-ND 3.0). Feel free to republish and share widely.

We've had enough. The 1% own and operate the corporate media. They are doing everything they can to defend the status quo, squash dissent and protect the wealthy and the powerful. The Common Dreams media model is different. We cover the news that matters to the 99%. Our mission? To inform. To inspire. To ignite change for the common good. How? Nonprofit. Independent. Reader-supported. Free to read. Free to republish. Free to share. With no advertising. No paywalls. No selling of your data. Thousands of small donations fund our newsroom and allow us to continue publishing. Can you chip in? We can't do it without you. Thank you.

'Terrible Idea': Biden Preparing to Shift Costs of Covid Treatments, Vaccines to Patients

"We must push back," said one doctor. "Free provision of vaccinations, Paxlovid, and monoclonals has been critically important."

Kenny Stancil ·


Trump-Appointed Judge Permanently Blocks Biden's Oil and Gas Leasing Moratorium

Fossil fuel extraction on federal lands and waters has accounted for an estimated 25% of all U.S. carbon emissions since 2005.

Jake Johnson ·


In Landslide 1,108-to-387 Vote, Maine Nurses Reject Effort to Decertify Their Union

"They thought because we were a new union, they could manipulate Maine Med nurses and overturn our 2021 election," said one nurse. "But we just showed them the door."

Jake Johnson ·


Dems Threaten to Subpoena FTI Consulting Over 'Blanket Refusal' to Provide Info on Fossil Fuel Work

"FTI's refusal to cooperate with this congressional inquiry shows that they have something to hide, which will reveal the dangerous ways agencies like theirs have promoted fossil fuel greenwash and misinformation," said the Clean Creatives campaign's leader.

Jessica Corbett ·


Bad Day for DeSantis as 'Stop WOKE Act' Hit With Injunction, Lawsuit

"If Florida truly believes we live in a post-racial society, then let it make its case," a federal judge wrote in blocking part of the controversial law. "But it cannot win the argument by muzzling its opponents."

Brett Wilkins ·

Common Dreams Logo